HoldingsChannel.com
Odonate Therapeutics insider buying image
The table below summarizes the most recent Odonate Therapeutics insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why Odonate Therapeutics insider buys are important for investors to follow.
DateInsiderPriceAmount
12-10-2021
Insider Buy		 EcoR1 Capital, LLC
>10% Owner		 $1.66
CAGR » 		$308,662.06
185,941 shares
12-29-2020
Insider Buy		 Craig A. Johnson
Director		 $17.00
CAGR » 		$51,000.00
3,000 shares
12-30-2020
Insider Buy		 Aaron I. Davis
Director and >10% Owner		 $17.16
CAGR » 		$6,863,427.50
400,000 shares
12-30-2020
Insider Buy		 Boxer Capital, LLC
Director and >10% Owner		 $17.16
CAGR » 		$6,863,427.50
400,000 shares
12-23-2020
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $15.16
CAGR » 		$4,181,207.92
275,784 shares
9-29-2020
Insider Buy		 Boxer Capital, LLC
Director and >10% Owner		 $13.63
CAGR » 		$2,932,156.00
215,200 shares
9-29-2020
Insider Buy		 Aaron I. Davis
Director and >10% Owner		 $13.63
CAGR » 		$2,932,156.00
215,200 shares
9-29-2020
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $13.13
CAGR » 		$1,456,408.29
110,882 shares
9-9-2020
Insider Buy		 Boxer Capital, LLC
Director and >10% Owner		 $14.98
CAGR » 		$3,371,631.00
225,000 shares
9-9-2020
Insider Buy		 Aaron I. Davis
Director and >10% Owner		 $14.98
CAGR » 		$3,371,631.00
225,000 shares
8-28-2020
Insider Buy		 Aaron I. Davis
Director and >10% Owner		 $14.25
CAGR » 		$20,000,003.25
1,403,509 shares
8-28-2020
Insider Buy		 Boxer Capital, LLC
Director and >10% Owner		 $14.25
CAGR » 		$20,000,003.25
1,403,509 shares
8-28-2020
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $14.25
CAGR » 		$14,999,991.75
1,052,631 shares
6-26-2019
Insider Buy		 Jeff L. Vacirca
Director		 $26.00
CAGR » 		$500,006.00
19,231 shares
6-26-2019
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $26.00
CAGR » 		$20,000,006.00
769,231 shares
6-26-2019
Insider Buy		 Boxer Capital, LLC
>10% Owner		 $26.00
CAGR » 		$9,999,990.00
384,615 shares
6-18-2019
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $26.15
CAGR » 		$1,307,545.60
50,000 shares
6-7-2019
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $27.36
CAGR » 		$2,087,456.83
76,308 shares
6-5-2019
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $24.92
CAGR » 		$2,335,216.80
93,692 shares
3-4-2019
Insider Buy		 Jeff L. Vacirca
Director		 $17.00
CAGR » 		$50,999.80
3,000 shares
12-18-2018
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $14.67
CAGR » 		$586,638.90
40,000 shares
3-8-2019
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $18.26
CAGR » 		$2,556,316.08
140,000 shares
12-31-2018
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $13.11
CAGR » 		$835,106.86
63,700 shares
12-26-2018
Insider Buy		 Boxer Capital, LLC
Director and >10% Owner		 $13.27
CAGR » 		$1,658,830.00
125,000 shares
12-26-2018
Insider Buy		 Aaron I. Davis
Director and >10% Owner		 $13.27
CAGR » 		$1,658,830.00
125,000 shares
12-26-2018
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $12.60
CAGR » 		$755,856.75
60,000 shares
12-18-2018
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $14.67
CAGR » 		$586,638.90
40,000 shares
12-12-2018
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $15.60
CAGR » 		$312,073.27
20,000 shares
12-7-2018
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $14.79
CAGR » 		$295,863.90
20,000 shares
11-27-2018
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $15.64
CAGR » 		$47,912.36
3,063 shares
11-26-2018
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $15.29
CAGR » 		$259,017.24
16,937 shares
11-1-2018
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $14.87
CAGR » 		$148,727.00
10,000 shares
10-29-2018
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $14.98
CAGR » 		$153,366.75
10,235 shares
10-24-2018
Insider Buy		 Boxer Capital, LLC
Director and >10% Owner		 $14.72
CAGR » 		$394,752.71
26,824 shares
10-24-2018
Insider Buy		 Aaron I. Davis
Director and >10% Owner		 $14.72
CAGR » 		$394,752.71
26,824 shares
10-25-2018
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $15.35
CAGR » 		$610,300.59
39,765 shares
9-26-2018
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $19.75
CAGR » 		$789,973.00
40,000 shares
9-20-2018
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $19.55
CAGR » 		$1,759,295.75
90,000 shares
8-21-2018
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $19.47
CAGR » 		$146,150.87
7,505 shares
8-20-2018
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $19.49
CAGR » 		$968,273.62
49,685 shares
8-15-2018
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $18.93
CAGR » 		$431,704.67
22,810 shares
3-26-2018
Insider Buy		 Aaron I. Davis
Director and >10% Owner		 $22.73
CAGR » 		$2,273,153.36
100,000 shares
3-26-2018
Insider Buy		 Boxer Capital, LLC
Director and >10% Owner		 $22.73
CAGR » 		$2,273,153.36
100,000 shares
3-1-2018
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $27.42
CAGR » 		$385,181.84
14,050 shares
2-27-2018
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $27.42
CAGR » 		$784,638.03
28,612 shares
2-22-2018
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $27.17
CAGR » 		$1,061,811.05
39,083 shares
2-16-2018
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $22.47
CAGR » 		$2,881,343.79
128,255 shares
12-12-2017
Insider Buy		 Jeff L. Vacirca
Director		 $23.30
CAGR » 		$23,300.00
1,000 shares
12-6-2017
Insider Buy		 Boxer Capital, LLC
Director and >10% Owner		 $24.00
CAGR » 		$9,999,984.00
416,666 shares
12-6-2017
Insider Buy		 Aaron I. Davis
Director and >10% Owner		 $24.00
CAGR » 		$9,999,984.00
416,666 shares
12-7-2017
Insider Buy		 Kevin C. Tang
Chief Executive Officer		 $24.00
CAGR » 		$30,999,984.00
1,291,666 shares

Also See: Institutional Holders of ODT
Also See: SEC filings

ODT Performance Since Insider Purchase
Below we present the annualized performance delivered by Odonate Therapeutics stock since 12-10-2021 (the date of the most recent insider purchase). The performance of the investment from the time Odonate Therapeutics insider buying occurred is the ultimate test of whether insiders were right about ODT being a good buy.

Growth of $10,000.00
Without Dividends Reinvested
Start date: 12/13/2021
End date: 01/14/2022
Start price/share: $1.46
End price/share: $1.12
Dividends collected/share: $0.00
Total return: -23.29%
Annualized Gain: -265.62%
Starting investment: $10,000.00
Ending investment: $7,671.00
Years: 0.09

Odonate Therapeutics Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Odonate Therapeutics insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding ODT

ODT — Current Quote
Quotes delayed 20 minutes

Email EnvelopeFree ODT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

ODT — Performance

Odonate Therapeutics Insider Buying | www.HoldingsChannel.com

Copyright © 2013 - 2024, All Rights Reserved Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.